Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 31, Number 9—September 2025

Research

Theileria luwenshuni and Novel Babesia spp. Infections in Humans, Yunnan Province, China

Rong Xiang1, Chun-Hong Du1, Yi-Lin Zhao1, Zhi Luo, Miao Li, Dan-Ni Zeng, Fan Wang, Chao-Bo Du, Yi SunComments to Author , Qiao-Cheng ChangComments to Author , and Jia-Fu JiangComments to Author 
Author affiliation: Author affiliations: State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, China (R. Xiang, Y.-L. Zhao, D.-N. Zeng, Y. Sun, J.-F. Jiang); Yunnan Institute of Endemic Disease Control and Prevention, Dali, China (C.-H. Du, Z. Luo, M. Li, F. Wang, C.-B. Du ); School of Public Health at Shantou University, Shantou, China (Q.-C. Chang)

Main Article

Table 1

Characteristics of 18 patients hospitalized for Theileria luwenshuni and Babesia spp. infection, China*

Characteristic T. luwenshuni cases, n = 13 Babesia spp. cases, n = 5
Age, y (IQR)
40 (32.5–68.0)
56 (25.5–59.5)
Sex
M 10 (77) 4 (80)
F
3 (23)
1 (20)
Length of hospital stay, d (IQR) 13 (7.5–17.0) 10 (5.5–10.5)
Occupation as farmer
13 (100)
5 (100)
Medical history and underlying disease
Renal failure 5 (38) 1 (20)
Cancer 3 (23) 0
Upper gastrointestinal bleeding
5 (38)
3 (60)
Clinical manifestations†
Nonspecific symptoms
Dizziness 3 (23) 4 (80)
Malaise 5 (38) 4 (80)
Cough 1 (8) 0
Jaundice 1 (8) 0
Splenomegaly 1 (8) 0
Weight loss 1 (8) 0
Cardiovascular manifestations
Chest discomfort 1 (8) 1 (20)
Palpitations 3 (23) 1 (20)
Dyspnea 2 (15) 1 (20)
Gastrointestinal manifestations
Anorexia 8 (62) 2 (40)
Vomiting 4 (31) 0
Bloating 1 (8) 1 (20)
Stomachache 1 (8) 0
Hematemesis 3 (23) 0
Melena 4 (31) 3 (60)
Neurologic manifestations
Syncope 1 (8) 1 (20)
Listlessness
8 (62)
2 (40)
Laboratory findings
Anemia 13 (100) 5 (100)
Leukocytosis 2 (15) 1 (20)
Elevated serum AST or ALT or γ-GGT concentration 1 (8) 0

*Values are no. (%) patient except as indicated. ALT, alanine aminotransferase; AST, aspartate aminotransferase; γ-GGT, gamma-glutamyl transferase; IQR, interquartile range. †Patients could report >1 symptom.

Main Article

1These authors contributed equally to this article.

Page created: July 17, 2025
Page updated: August 26, 2025
Page reviewed: August 26, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external